Dexcel Pharma Technologies Ltd.
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to Dexcel Pharma Technologies Ltd.. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| ROIV | Purchase | 8,600 | $3.91 | $33,626 | Apr 22, 2022 | |
| 0001638381 | Sale | 110,000 | $0.29 | $31,900 | Jan 31, 2020 | |
| 0001740547 | Purchase | 6,541 | $8.53 | $55,795 | Jun 19, 2019 | |
| 0001740547 | Purchase | 7,367 | $7.95 | $58,568 | Jun 12, 2019 | |
| 0001740547 | Purchase | 7,189 | $8.58 | $61,682 | Jun 10, 2019 | |
| 0001740547 | Purchase | 7,082 | $8.00 | $56,656 | Jun 5, 2019 | |
| 0001679082 | Purchase | 2,424,242 | $8.25 | $19,999,997 | Jun 4, 2019 | |
| 0001740547 | Purchase | 6,951 | $7.97 | $55,399 | May 30, 2019 | |
| 0001740547 | Purchase | 1,715 | $8.39 | $14,389 | May 20, 2019 | |
| 0001740547 | Purchase | 2,678,571 | $14.00 | $37,499,994 | Oct 1, 2018 |